✦ LIBER ✦

Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists

✍ Scribed by Derek Kyte,Jonathan Ives,Heather Draper,Thomas Keeley,Melanie Calvert

Book ID: 126377152
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 120 KB
Volume: 14
Category: Article
ISSN: 1468-6708
DOI: 10.1186/1745-6215-14-S1-O56

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Statistical analysis of quality of life

Statistical analysis of quality of life with missing data in cancer clinical trials

✍ Andrea B. Troxel; Diane L. Fairclough; Desmond Curran; Elizabeth A. Hahn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 3 views

We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials, especially those related to missing data. We describe different types of missing data mechanisms, and discuss ways of assessing and testing missing data mechanisms. A section on presentation of stud

Missing data in quality of life research

Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions

✍ Elizabeth A. Hahn; Kimberly A. Webster; David Cella; Diane L. Fairclough 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

Incorporation of quality of life (QOL) investigation into Eastern Cooperative Oncology Group (ECOG) multi-centre clinical trials has led to innovative strategies for protocol design and high quality data collection. A scientific advisory committee reviews protocol design components, measurement sele

PSS38 USE OF CALL CENTRE METHODOLOGY TO

PSS38 USE OF CALL CENTRE METHODOLOGY TO COLLECT QUALITY OF LIFE (QOL) DATA IN A CLINICAL TRIAL: A CASE STUDY OF PATIENTS WITH DIABETIC MACULAR EDEMA (DME)

✍ J Loftus; A Pleil; J Li; S Wallace 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Evaluating health-related quality-of-lif

Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer

✍ Carol M. Moinpour, Gary W. Donaldson, Astra M. Liepa, Allen S. Melemed, Joyce O’ 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 392 KB